2-(3-chloro-4-fluoro-phenoxy)-nicotinic acid | 83164-85-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(3-chloro-4-fluoro-phenoxy)-nicotinic acid
• 英文别名: 2-(3-chloro-4-fluorophenoxy)pyridine-3-carboxylic acid
• CAS: 83164-85-6
• 化学式: C₁₂H₇ClFNO₃
• mdl: MFCD19021026
• 分子量: 267.644
• InChiKey: QEWYFCDGRNQAEE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(3-chloro-4-fluoro-phenoxy)-nicotinic acid 生成 2-(3-chloro-4-fluorophenoxy)-N-(4-fluorophenyl)pyridine-3-carboxamide
  参考文献：
  名称：

  CRAMP, M. C.;GILMOUR, J.;PARNELL, E. W.

  摘要：

  DOI：

文献信息

• NOVEL PHENYL AMIDE OR PYRIDYL AMIDE DERIVATIVES
  申请人：Bissantz Caterina

  公开号：US20100105906A1

  公开（公告）日：2010-04-29

  This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula wherein A 1 , A 2 , B 1 , B 2 and R 1 to R 11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

  这项发明涉及公式的新型苯基酰胺或吡啶基酰胺衍生物 其中A1、A2、B1、B2和R1到R11如描述和索赔中所定义，以及其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗诸如2型糖尿病等疾病的药物。
• Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
  申请人：Sekiguchi Yoshinori

  公开号：US20050197350A1

  公开（公告）日：2005-09-08

  The present invention relates to novel compounds of the Formula (I): which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.

  本发明涉及一种新的化合物，其化学式为(I)，该化合物作为MCH受体拮抗剂。这些组合物在制药组合物中的应用包括预防或治疗改善记忆功能、睡眠和觉醒、焦虑、抑郁、情绪障碍、癫痫、肥胖症、糖尿病、食欲和进食障碍、心血管疾病、高血压、血脂异常、心肌梗死、暴食症包括贪食症、厌食症、精神障碍包括躁郁症、精神分裂症、谵妄、痴呆、压力、认知障碍、注意力缺陷障碍、物质滥用障碍和运动障碍包括帕金森病、癫痫和成瘾等。
• Substituted pyridines as GPBAR1 agonists
  申请人：Hoffmann-La Roche Inc.

  公开号：US08309734B2

  公开（公告）日：2012-11-13

  This invention relates to novel phenyl amide or pyridyl amide derivatives of the formula wherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

  本发明涉及新型苯基酰胺或吡啶基酰胺衍生物，其化学式如下： 其中A1、A2、B1、B2和R1至R11在说明书和权利要求书中定义，以及其药学上可接受的盐。这些化合物是GPBAR1激动剂，可用作治疗2型糖尿病等疾病的药物。
• New herbicidal nicotinamide derivatives
  申请人：MAY & BAKER LIMITED

  公开号：EP0053011A1

  公开（公告）日：1982-06-02

  Nicotinamide derivatives of the formula:- (wherein X represents an oxygen or sulphur atom, R1 represents a hydrogen atom or a methyl, ethyl or allyl group, R2 represents a hydrogen, fluorine or chlorine atom, a cyano group or a methyl or ethyl group optionally substituted by one or more fluorine atoms, R3 represents a fluorine, chlorine or bromine atom or a cyano, trifluoromethyl, methoxy, ethoxy, trifluoromethoxy or C1-4 alkanesulphonyl group, one of R4 and R5 represents a hydrogen atom and the other represents a hydrogen, fluorine, chlorine or bromine atom or a cyano, trifluoromethyl, methoxy, ethoxy, trifluoromethoxy or C1-4 alkanesulphonyl group, R6 represents a hydrogen, fluorine or chlorine atom or a cyano or ethynyl group, R7 represents a fluorine or chlorine atom, R8 represents a hydrogen, fluorine, chlorine or bromine atom or a methyl or ethyl group and m represents 0, 1 or 2, with the proviso that when R2 and R6 each represent a hydrogen atom; m represents 0, have been found to possess useful herbicidal properties; herbicidal compositions, methods for controlling the growth of weeds and processes for the preparation of the nicotinamide derivatives are described.

  式中的烟酰胺衍生物：- 其中 X 代表氧原子或硫原子，R1 代表氢原子或甲基、乙基或烯丙基，R2 代表氢原子、氟原子或氯原子、氰基或任选被一个或多个氟原子取代的甲基或乙基、R3 代表氟、氯或溴原子或氰基、三氟甲基、甲氧基、乙氧基、三氟甲氧基或 C1-4 烷磺酰基，R4 和 R5 中的一个代表氢原子，另一个代表氢、R6 代表氢原子、氟原子或氯原子或氰基或乙炔基、R7 代表氟或氯原子，R8 代表氢、氟、氯或溴原子或甲基或乙基，m 代表 0、1 或 2，但当 R2 和 R6 各代表一个氢原子时，m 代表 0；m 代表 0 时，具有有用的除草特性；描述了除草组合物、控制杂草生长的方法和制备烟酰胺衍生物的工艺。
• QUINOLINE, TETRAHYDROQUINOLINE AND PYRIMIDINE DERIVATIVES AS MCH ANTAGONIST
  申请人：Taisho Pharmaceutical Co. Ltd.

  公开号：EP1464335A2

  公开（公告）日：2004-10-06

  The present invention relates to compounds of the Formula (I) wherein Q is: which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.

  本发明涉及式（I）化合物 其中 Q 为 作为 MCH 受体拮抗剂的化合物。这些组合物可用于药物组合物中，其用途包括预防或治疗改善记忆功能、睡眠和唤醒、焦虑、抑郁、情绪障碍、癫痫发作、肥胖、糖尿病、食欲和进食障碍、心血管疾病、高血压、血脂异常、心肌梗塞、暴饮暴食症（包括贪食症）、厌食症、心肌梗塞、暴食症（包括贪食症）、厌食症、精神障碍（包括躁狂抑郁症）、精神分裂症、谵妄、痴呆、压力、认知障碍、注意力缺陷障碍、药物滥用障碍和运动障碍（包括帕金森病）、癫痫和成瘾。